Dorine AKSAR

• Supported brand development initiatives by creating bilingual (EN/AR) digital content, product stories and visual assets across social media and marketing campaigns. • Coordinated packaging, artwork, regulatory files and cross-functional communication between marketing, design, operations and compliance teams. • Conducted market and competitor research to refine brand positioning across EU and GCC markets. • Maintained organised tracking tools for submissions, documentation and project timelines, ensuring smooth workflow and audit readiness. • Prepared and reviewed product dossiers, ingredient data and compliance files to support international regulatory submissions. • Managed supplier communication, approvals and documentation exchange to ensure accurate product information flow.

• Delivered clear, empathetic communication to patients and healthcare teams, translating complex medical information into accessible guidance. • Supported medical documentation, ADR reporting and pharmacovigilance activities aligned with MHRA standards. • Collaborated with multidisciplinary teams on treatment plans before and after surgery, ensuring consistency and accuracy. • Developed and delivered educational materials for both patients and clinicians. • Improved documentation workflows through accuracy checks, SOP alignment and process improvement activities.

• Prepared, reviewed and updated Product Information Files (PIFs) under EU Regulation (EC) No 1223/2009. • Checked ingredient lists, claims and labelling for compliance across skincare and fragrance collections. • Compiled safety documentation, supplier certificates and technical files for regulatory submissions. • Supported product communication by aligning technical information with marketing claims.

• Supported the design and documentation of research protocols for pharmaceutical formulations. • Conducted data collection, validation and reporting under GMP/GCP guidelines. • Collaborated with analytical and QA teams to ensure documentation integrity and regulatory compliance. • Strengthened understanding of coordination between R&D, regulatory, and quality units.

Silencing the expression of immunosuppressive immune checkpoints in Glioblastoma cultures using stable nucleic acid lipid nanoparticles.